| VRNA | VRTX | REGN | ALNY | ARGX | SGEN | |
|---|---|---|---|---|---|---|
| Company Name | Verona Pharma plc | Vertex Pharmaceuticals Incorporated | Regeneron Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | argenx SE | Seagen Inc. |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology |
| Market Cap | $72.68B | $108.04B | $68.01B | $60.75B | $50.28B | $43.15B |
| Employees | 0.21K | 6.10K | 15.16K | 2.23K | 1.60K | 3.26K |
| CEO | David S. Zaccardelli | Reshma Kewalramani FASN, | Leonard S. Schleifer | Yvonne L. Greenstreet | Timothy Van Hauwermeiren EMBA, | David R. Epstein |